key: cord-0949472-v6zz498e
authors: Tao, Fenghua; Tang, Xiaoyan; Tao, Hai; Luo, Yue; Cao, Hui; Xiang, Wei; Zhao, Yingchun; Jin, Lin
title: Surgical treatment of diabetic foot ulcers during the COVID-19 pandemic in China
date: 2020-05-14
journal: J Diabetes Complications
DOI: 10.1016/j.jdiacomp.2020.107622
sha: f60815bb899abe15d56afe62d4253bf6265cbf65
doc_id: 949472
cord_uid: v6zz498e

Abstract Diabetic foot ulcers are among the most serious complications of diabetes. If left untreated, these ulcers can lead to severe infection and gangrene; in some instances, they may result in death. Thus, timely treatment of diabetic foot ulcers is extremely important. However, timely patient treatment during the COVID-19 pandemic is particularly challenging, because of the higher volume of patients and the need to ensure safety of medical personnel. This article describes a proposed strategy for diagnosis and treatment of diabetic foot ulcers, based on experiences with infection and control strategies during the COVID-19 pandemic in China.

In Diseases. China has also adopted measures for prevention and control of a Class A infectious disease, and has called for a level one response from major public health emergencies.

Medical personnel in Wuhan were infected by the virus in large numbers. From among the 422 medical institutions used to treat patients with COVID-19, a total of 3019 medical staff were infected and five died [1] . The COVID-19 outbreak has threatened human health and greatly J o u r n a l P r e -p r o o f 3 epidemiological data of 138 patients with COVID-19 was published; among the critically ill patients in that study, 22 .2% had diabetes. The proportion of patients with comorbid diabetes was also high among the patients who died [3] .

Diabetic foot ulcers (DFUs) constitute a serious chronic condition resulting from diabetes complications. Approximately 10-15% of patients with diabetes develop foot ulcers [4] ; of those patients, more than half develop infections [5] . The incidence of amputations in patients with moderate or severe DFUs is approximately 20% [6] ; approximately one million patients worldwide undergo amputation due to DFUs each year [7] . DFUs are estimated to cause approximately 20% of hospitalizations in patients with diabetes; the 5-year risk of death for patients with DFUs is 2.5fold greater than that of patients without DFUs [8] . Therefore, it is important to reduce hospitalrelated COVID-19 transmission and optimize the diagnosis and treatment of DFUs to ensure safety for patients with diabetes.

As the designated hospital for treatment of patients with severe COVID-19, the Renmin Hospital of Wuhan University has experience treating patients with COVID-19 who have DFUs. contact with individuals who have COVID-19, and whether patients exhibit COVID-19 symptoms such as fever, cough, dyspnea, and weakness [9] . Some patients with DFUs may exhibit fever due to COVID-19; this fever is generally low-or middle-grade with respiratory symptoms. In other patients, loss of smell and taste has also been reported.

During the COVID-19 pandemic, prevention and control of nosocomial infection has been important. To ensure the safety of medical personnel and avoid nosocomial infections, each medical doctor should be familiar with methods to prevent and control such infections, including the clinical manifestations, epidemiological characteristics, diagnosis, and treatment of COVID-19.

Blood and chest computed tomography are recommended as routine examinations for outpatient emergency departments, as these will facilitate rapid and accurate screening for COVID-19.

Computed tomography procedures require special machinery and disinfection procedures, in accordance with national regulations.

The clinical symptoms of COVID-19 are not specific, with fever, fatigue, and dry cough, whilst other symptoms such as loss of smell and taste have also been documented. During the early stages of COVID-19 onset, the total number of white blood cells can be normal or low, while the lymphocyte count is low, compared with healthy individuals. Most patients have higher C-reactive protein, higher erythrocyte sedimentation rate, and normal procalcitonin. Lower respiratory tract secretions can be used for SARS-CoV-2 nucleic acid testing (i.e., the causative agent of COVID- 19) , and lung imaging shows characteristics similar to those of pneumonia, which are ground-glass opacities (GGOs) and consolidation with or without vascular enlargement, interlobular septal thickening, and air bronchogram sign. Preliminary screening J o u r n a l P r e -p r o o f COVID-19, respiratory specimens should be collected and submitted for SARS-CoV-2 nucleic acid testing as soon as possible. Individuals who have come in close contact with patients who have COVID-19 should also undergo SARS-CoV-2 nucleic acid testing.

Patients with DFUs may also have fever symptoms; these are typically accompanied by local redness, swelling, pain, inflammatory secretions, elevated inflammatory response indicators (e.g., white blood cells, C-reactive protein, erythrocyte sedimentation rate, and/or procalcitonin), and positive wound bacterial culture. Patients who meet the diagnostic criteria for confirmed or suspected COVID-19 should be transferred to a designated hospital as soon as possible. If the unit has conditional admission or infected patients cannot be transferred immediately, infected patients should be isolated in a single room; medical staff should use level three protection measures, which refer to using protective masks (N95 or above), protective clothing, disposable caps, shoe covers, gloves, as well as goggles and respiratory protectors. Medical staff should ensure that they wear and remove this protective equipment correctly, pay close attention to personal hygiene, and protect their respiratory tract, oral cavity, nasal mucosa and eyes.

Poor glycemic control has been reported as a key predisposing factor for DFUs [11] . A reasonable glycemic control during the treatment of DFUs could facilitate ulcer healing without increase of mortality in patients with DFUs [12] . Glycemic control is important in any patient who has COVID-19, since patients with poor glycemic control have increased risk of complications and death [13] . Blood glucose monitoring is essential. Insulin therapy to control blood glucose levels is recommended in this patient group, and glucose levels should be measured before breakfast, two hours after each meal, and before bedtime.

In accordance with the diagnostic criteria set out in the COVID-19 Diagnosis and Treatment J o u r n a l P r e -p r o o f 6 one long-acting insulin dose. The corresponding insulin dose adjustments can be made in accordance with the patient's meal intake and results of blood glucose monitoring [14] . For patients with severe and critical COVID-19, glucose control should be performed by means of continuous intravenous pump insulin infusions. Insulin dose adjustments are based on blood glucose monitoring. If blood glucose is difficult to control or if the patient experiences acute complications of diabetes, an endocrinologist should be consulted to establish a blood glucose control plan.

During treatment of DFUs, it is essential to adhere to the "safety rescue principle," effective protection protocols, and evidence-based treatment. Medical care and patient safety should be regarded as equally important goals to avoid unnecessary contamination and to prevent transmission.

During critical stages of COVID-19 prevention and treatment, stricter processes are needed for standard surgical procedures. A multi-disciplinary team is also recommended [15] , and elective surgery (such as vacuum sealing drainage, transverse tibial bone transport technique, arterial reconstruction) should be temporarily postponed. In patients who require limited surgery (such as interventional treatment, amputation), operations can be delayed as appropriate when such delays do not affect the current condition or its treatment; this plan must be properly communicated to affected patients. For patients who require emergency surgery (debridement, local decompression), the normal surgical procedure can be followed when COVID-19 has been [17] .

In cases with infected diabetic foot ulcers, local abscesses, a severe inflammatory reaction, or even septic shock, local treatment is urgently required for drainage and control of systemic infection. Patients with irreversible necrosis of the limbs, progressive infection, toxin absorption leading to severe liver and kidney dysfunction, or septic shock, and those in whom non-surgical J o u r n a l P r e -p r o o f 10 administered. For patients with relatively small DFUs associated with mild infections (i.e., Wagner grades I and II), doctors can perform simple debridement under local anesthesia, using level three protection measures in an isolation ward. Regular wound dressing changes and new dressings for ulcers should also be supplied as required. These procedures must be supplemented with local offloading treatments, such as total contact plaster support, removable plaster support, half boots, modified surgical shoes, foot plaster, and any other necessary treatments. This process enables DFU healing and gradual improvement for most patients [20, 21] ; for a small number of patients with poor results, this process provided additional time until secondary surgery was necessary.

Diabetic peripheral vascular disease involves small and medium arteries, resulting in poor compensation of collateral circulation and peripheral neuropathy. Therefore, patients with diabetic peripheral vascular disease have a higher rate of disability, compared to patients with non-diabetic vascular disease.

Percutaneous transluminal angioplasty (PCTA) is the gold standard for placement of narrow blood vessels with or without stents; it can also improve blood flow and promote healing in a timely manner. PCTA is essential when peripheral vascular disease endangers limb survival and conservative treatment fails. The use of PCTA can save limbs by avoiding amputation or reducing the level of amputation [22] ; this treatment has a success rate of 80-90% and a 2-year limb salvage rate of 86% [23] . In contrast to traditional open surgery, PCTA uses local anesthesia and is minimally invasive. Furthermore, patients have higher tolerance, lower surgical complications, and lower mortality.

Most interventional operating rooms are not negative-pressure operating rooms and require terminal disinfection after surgery. All patients undergoing PCTA surgical treatment require level three protection. After treatment, they can be returned to the isolation ward. Notably, PCTA treatment is suitable for patients with mild and moderate COVID-19. Given that patients with severe and critical COVID-19 are in critical condition, this procedure must be carefully considered; J o u r n a l P r e -p r o o f 11 it involves patient transfer, a lack of rescue equipment in the intervention room, and the potential for worsened disease after surgery.

Severe DFUs are often associated with deep local abscesses, subfascial abscesses, septic arthritis, osteomyelitis, and necrotizing fasciitis on the feet or legs; they are also often infected by multiple microorganisms. Treatments for these infections are frequently unsuccessful; thus, such infections constitute the main cause of amputation in patients with diabetes. In patients with severe DFUs, the infection can cause septic shock and is life-threatening [24] . Therefore, debridement surgery is necessary for severely infected ulcers and is considered a surgical emergency.

There is a high rate of amputation in patients with DFUs, which can be life-threatening.

According to Wagner's classification standard, higher classification indicates greater ulcer area, greater depth, and greater degree of infection. These characteristics are associated with a higher rate of amputation. Patients with Wagner grades IV and V DFUs have irreversible damage in the lower limbs, often accompanied by severe vascular disease or ischemic infection. To save the life of an affected patient, amputation may be the only available treatment option [25] . For patients with DFUs who have previous failed amputations and require additional amputation for gangrene infection, their conditions must be carefully considered; effective limbs should be retained when possible. Before amputation, other alternative treatments should be considered first [26] . should be maintained below -5 Pa. All medical staff participating in the surgery should wear personal protective equipment according to level three protection requirements [27] . The If patients with DFUs require other surgical treatments (e.g., negative pressure wound therapy, tibia lateral bone movement technology, vascular reconstruction technology, and others) that do not endanger life and limb function, or are limited operations, it is recommended to wait until the COVID-19 pandemic has ended.

Thus far, COVID-19 has been effectively controlled in China; however, COVID-19 is now a worldwide pandemic that presents a considerable challenge for healthcare workers. In this context, the traditional treatment strategy for DFUs has limitations. The guidance provided in this article is 

Epidemiology Working Group for NCIP Epidemic Response. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan

Diabetic Foot Ulcers and Their Recurrence

High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe: baseline results from the Eurodiale study

Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections

Educating patients of diabetes mellitus for diabetic foot care

Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom

The COVID-19 epidemic

Understanding of COVID-19 based on current evidence

Correlation between superficial and intra-operative specimens in diabetic foot infections: results of a cross-sectional Tunisian study

Reasonable glycemic control would help wound healing during the treatment of diabetic foot ulcers

Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations

Clinical considerations for patients with diabetes in times of COVID-19 epidemic

Recommendations for general surgery clinical practice in novel coronavirus pneumonia situation

Managing Patients With Diabetic Foot Ulcers. Wounds

Emergency Surgery Score Accurately Predicts the Risk of Post-Operative Infection in Emergency General Surgery

Characteristics of COVID-19 infection in Beijing

The diabetic foot

Effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral artery disease: a systematic review

IWGDF guidance on footwear and offloading interventions to prevent and heal foot ulcers in patients with diabetes

The use of debridement in the healing of diabetic foot ulcers

Prevention and treatment of diabetic foot ulcers

Cost-effectiveness of prevention and management of diabetic foot ulcer and amputation in a health resource-limited setting

Percutaneous coronary intervention vs. cardiac surgery in diabetic patients. Where are we now and where should we be going

Chopart Amputation: Questioning the Clinical Efficacy of a Long-standing Surgical Option for Diabetic Foot Infection

Recommendations for general surgery clinical practice in novel coronavirus pneumonia situation